JESSICA SPRINGER: Open Payments
NPI 1568829059 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 29 payments from 16 companies in 2025. Trend: 2023 $34 · 2024 $36 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 6 | $418 |
| TG Therapeutics, Inc. | 2 | $135 |
| Lilly USA, LLC | 1 | $125 |
| Genentech USA, Inc. | 2 | $60 |
| ABBVIE INC. | 3 | $60 |
| Eisai Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Neurelis, Inc. | 1 | $30 |
| ARGENX US, INC. | 1 | $25 |
Products named: Mavenclad, BRIUMVI, KISUNLA, Ocrevus Zunovo, Leqembi, QULIPTA, REXULTI, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
